Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Domenico Bilancia"'
Autor:
Giuseppe Di Lorenzo, Aieta Michele, Leo Silvana, Domenico Bilancia, Rossella Di Trolio, Michela Rosaria Iuliucci, Concetta Ingenito, Roberta Rubino, Arianna Piscosquito, Michele Caraglia, Marianna Donnarumma, Ferdinando Costabile, Raffaele Conca, Marco Pisino, Angelo Vaia, Luca Scafuri, Antonio Verde, Carlo Buonerba
Publikováno v:
Oncology and Therapy, Vol 12, Iss 1, Pp 147-155 (2023)
Abstract Introduction This retrospective study investigates the efficacy of cemiplimab, a monoclonal antibody targeting the PD-1 receptor, in treating squamous cell carcinoma (SCC) of the skin. Methods The study analyzes data from 50 patients with SC
Externí odkaz:
https://doaj.org/article/f13c9b0efbd74c45bab0d33196e8637f
Autor:
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, Raimondo Di Liello, Gessica Migliaccio, Daniela Barberio, Michelino De Laurentiis, Francesca Di Rella, Francesco Nuzzo, Carmen Pacilio, Giovanni Iodice, Michele Orditura, Fortunato Ciardiello, Sara Di Bella, Luigi Cavanna, Camillo Porta, Filippo Giovanardi, Carla Ida Ripamonti, Domenico Bilancia, Giuseppe Aprile, Tommaso Ruelle, Francesca Diodati, Maria Carmela Piccirillo, Elisabetta Iannelli, Carmine Pinto, Francesco Perrone
Publikováno v:
Breast, Vol 77, Iss , Pp 103781- (2024)
Patients’ self-reporting is increasingly considered essential to measure quality-of-life and treatment-related side-effects. However, if multiple patient-reported instruments are used, redundancy may represent an overload for patients.Patient-Repor
Externí odkaz:
https://doaj.org/article/71e5c3ed11094be79d7a7512d079914a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundMetastatic colorectal cancer is one of the most common causes of cancer death worldwide, and its incidence increases with age. Treating an older RAS and BRAF wild-type patient represents a challenge for the medical oncologist, even more so
Externí odkaz:
https://doaj.org/article/c561050b021f47e8a0eb3a52fd1e66e9
Autor:
Tiziana Latronico, Tania Petraglia, Carmela Sileo, Domenico Bilancia, Rocco Rossano, Grazia Maria Liuzzi
Publikováno v:
Molecules, Vol 29, Iss 8, p 1718 (2024)
Polyphenols, the main antioxidants of diet, have shown anti-inflammatory, antioxidant and anticarcinogenic activities. Here, we compared the effects of four polyphenolic compounds on ROS production and on the levels of matrix metalloproteinase (MMP)-
Externí odkaz:
https://doaj.org/article/7663503dae6f420e9b69422b38e2ccab
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 1, Pp 105-116 (2021)
Cancer metastasis is a stage of the disease where therapy is mostly ineffective; hence, the need to find reliable markers of its onset. The metalloproteinase-9 (MMP-9, gelatinase B) in its 82 kDa active form, is a good candidate, but here we show tha
Externí odkaz:
https://doaj.org/article/d046c72b964d407db1362d2cdf00de70
Autor:
Roberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, Rosalba Torrisi, Ida Paris, Monica Giordano, Vincenzo Montesarchio, Valentina Guarneri, Laura Amaducci, Domenico Bilancia, Giuseppina Cilenti, Alessandra Fabi, Elena Collovà, Alessio Schirone, Erminio Bonizzoni, Luigi Celio, Sabino De Placido, Michelino De Laurentiis
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background NEPA is an oral fixed-dose combination of netupitant, a new highly selective neurokinin-1 receptor antagonist, and palonosetron. This study was conducted to evaluate whether the efficacy of NEPA against chemotherapy-induced nausea
Externí odkaz:
https://doaj.org/article/fb8f35eeef8b488d89697747b69adae4
Autor:
Gerardo Rosati, Michele Montrone, Carmen Pacilio, Alfredo Colombo, Giuseppe Cicero, Fernando Paragliola, Angelo Vaia, Luigi Annunziata, Domenico Bilancia
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 23, p 7108 (2022)
Although colorectal cancer is increasingly being diagnosed in older patients, their number is largely underrepresented in phase II or III clinical trials. Consequently, guidelines and the SIOG recommendations are not sufficiently clear regarding the
Externí odkaz:
https://doaj.org/article/74a1de8c00d347f58434804f4bfe53e9
Autor:
Francesca Carlino, Anna Diana, Anna Ventriglia, Antonio Piccolo, Carmela Mocerino, Ferdinando Riccardi, Domenico Bilancia, Francesco Giotta, Giulio Antoniol, Vincenzo Famiglietti, Salvatore Feliciano, Rodolfo Cangiano, Lorenzo Lobianco, Benedetta Pellegrino, Ferdinando De Vita, Fortunato Ciardiello, Michele Orditura
Publikováno v:
Cancers, Vol 14, Iss 20, p 4981 (2022)
Background: Approximately 45–50% of breast cancers (BCs) have a HER2 immunohistochemical score of 1+ or 2+ with negative in situ hybridization, defining the “HER2-low BC” subtype. No anti-HER2 agents are currently approved for this subgroup in
Externí odkaz:
https://doaj.org/article/6f160ee106094b7faf94c0816e54b145
Autor:
Gerardo Rosati, Giuseppe Aprile, Alfredo Colombo, Stefano Cordio, Marianna Giampaglia, Alessandro Cappetta, Concetta Maria Porretto, Alfonso De Stefano, Domenico Bilancia, Antonio Avallone
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1035 (2022)
Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients. RAS and BRAF inhibitors have been developed for patients who become unresponsiv
Externí odkaz:
https://doaj.org/article/11352cc258214c51ab2b246869c379dd
Autor:
Carmine Pinto, Francesca Di Fabio, Gerardo Rosati, Ivan R. Lolli, Enzo M. Ruggeri, Libero Ciuffreda, Daris Ferrari, Giovanni Lo Re, Giovanni Rosti, Paolo Tralongo, Raimondo Ferrara, Oscar Alabiso, Silvana Chiara, Giovanni P. Ianniello, Antonio Frassoldati, Domenico Bilancia, Giovanna A. Campanella, Carlo Signorelli, Patrizia Racca, Elena Benincasa, Maria Elena Stroppolo, Francesco Di Costanzo
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3272-3281 (2016)
Abstract Cetuximab improves efficacy when added to chemotherapy for metastatic colorectal cancer (mCRC). Effective management of skin reactions from cetuximab improves quality of life (QoL), and treatment compliance in clinical trials. No data are av
Externí odkaz:
https://doaj.org/article/1eec0ffc35d244c397d164368ed31c3d